Aerosolized ceftazidime for prevention of ventilator-associated pneumonia and drug effects on the proinflammatory response in critically ill trauma patients

Pharmacotherapy

Volumn 22, Issue 8, 2002, Pages 972-982

  Wood, G Christopher ^a   Boucher, Bradley A ^a   Croce, Martin A ^b   Hanes, Scott D ^a   Herring, Vanessa L ^a   Fabian, Timothy C ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME; HISTAMINE H2 RECEPTOR ANTAGONIST; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MIDAZOLAM; MORPHINE; PLACEBO; PROPOFOL; TUMOR NECROSIS FACTOR ALPHA; VECURONIUM; ANTIINFECTIVE AGENT; CYTOKINE;

ADULT; AEROSOL; ARTICLE; BACTERIUM CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HIGH RISK PATIENT; HUMAN; INFLAMMATION; INJURY; INTENSIVE CARE UNIT; MALE; OUTCOMES RESEARCH; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; VENTILATOR; ARTIFICIAL VENTILATION; CHEMISTRY; EMERGENCY HEALTH SERVICE; LUNG LAVAGE; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; UNIVERSITY HOSPITAL;

ADULT; AEROSOLS; ANTIBIOTICS, LACTAM; BRONCHOALVEOLAR LAVAGE FLUID; CEFTAZIDIME; CRITICAL ILLNESS; CYTOKINES; DOUBLE-BLIND METHOD; FEMALE; HOSPITALS, UNIVERSITY; HUMAN; MALE; MIDDLE AGE; PNEUMONIA; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; SUPPORT, NON-U.S. GOV'T; TRAUMA CENTERS; WOUNDS AND INJURIES; ANTI-BACTERIAL AGENTS; HUMANS; MIDDLE AGED;

EID: 0036021201     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.22.12.972.33596     Document Type: Article

References (48)

1. Pneumonia following closed head injury
2. Nosocomial pneumonia in ventilated patients: A cohort study evaluating attributable mortality and hospital stay
3. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients
4. Hospital-acquired pneumonia: Attributable mortality and morbidity
5. Nosocomial pneumonia and mortality among patients in intensive care units
6. Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome: Incidence, prognosis, and risk factors
7. Nosocomial infections and hospital deaths: A case-control study
8. Nosocomial pneumonia in patients receiving continuous mechanical ventilation
9. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients
10. Pneumonia: Incidence, risk factors, and outcome in injured patients
11. Nosocomial respiratory tract infections in multiple trauma patients: Influence of level on consciousness with implications for therapy
12. Identification of early predictors for post-traumatic pneumonia
13. Endotracheally administered gentamicin for the prevention of infections of the respiratory tract in patients with tracheostomy: A double-blind study
14. Endotracheal antibiotics for the prevention of tracheobronchial infection in tracheotomized unconscious patients: A comparative study of gentamicin and aminosidin-polymyxin B combination
15. Prevention of gram-negative bacillary pneumonia using polymyxin aerosol as prophylaxis: Effect on the incidence of pneumonia in seriously ill patients
16. Aerosol polymyxin and pneumonia in seriously ill patients
17. Prospective trials of dexamethasone and aerosolized gentamicin in the treatment of inhalation injury in the burned patient
18. Outbreak of nosocomial Flavobacterium meningosepticum respiratory infections associated with use of aerosolized polymyxin B
19. Prevention of pneumonia by endotracheal micronebulization of tobramycin
20. Prevention of gram-negative nosocomial bronchopneumonia by intratracheal colistin in critically ill patients
21. Aerosolized antibiotics in mechanically ventilated patients: Delivery and response
22. Aerosolization of imipenem/cilastatin prevents Pseudomonas-induced acute lung injury
23. Cephalosporins and inflammatory host reactions
24. Local production of interleukin-8 is associated with nosocomial pneumonia
25. Inflammatory mediators in BAL fluid as markers of evolving pneumonia in leukocytopenic patients
26. Inflammatory cytokines in the BAL of patients with ARDS: Persistent elevation over time predicts poor outcome
27. Inflammatory mediators in bronchoalveolar lavage fluid and plasma in leukocytopenic patients with septic shock-induced acute respiratory distress syndrome
28. Cytokines IL-1β, IL-6, and TNF-α enhance in vitro growth of bacteria
29. The injury severity score: A method for describing patients with multiple injuries and evaluating emergency care
30. ACCP/SCCM consensus conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
31. Utility of Gram's stain and efficacy of quantitative cultures for posttraumatic pneumonia: A prospective study
32. Nebuliser therapy in the intensive care unit
33. Aerosolized antimicrobial therapy in acutely ill patients
34. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution
35. An alternative method for determination of ceftazidime in plasma by high-performance liquid chromatography
36. APACHE II: A severity of disease classification system
37. Endotracheal and aerosol administrations of ceftazidime in patients with nosocomial pneumonia: Pharmacokinetics and absolute bioavailability
38. Ceftazidime pulmonary epithelial lining fluid concentrations during continuous and intermittent infusion in swine
39. Meta-analysis of randomized controlled trial of selective decontamination of the digestive tract
40. The role of selective digestive tract decontamination on mortality and respiratory tract infections: A meta-analysis
41. The prevention of ventilator-associated pneumonia
42. Choice of mechanical ventilator: Influence on nebulizer performance
43. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: Outcome correlations in a prospective study of 200 patients
44. Monotherapy versus β-lactam-aminoglycoside combination treatment for gram-negative bacteremia: A prospective, observational study
45. Different pattern of local and systemic release of proinflammatory and anti-inflammatory mediators in severely injured patients with chest trauma
46. Compartmentalized cytokine production within the human lung in unilateral pneumonia
47. Effects of antibiotic therapy on Pseudomonas aeruginosa-induced lung injury in a rat model